GLOBALIZATION OF NEUROLOGY: DEVELOPMENT OF THE WFN JOURNAL OF THE NEUROLOGICAL SCIENCESLISAK, Robert P.Neurology. 2014, Vol 82, Num 2, pp 172-173, issn 0028-3878, 2 p.Article

Repair and retention of neuronal structures in multiple sclerosis: Identifying markers, metrics, and correlates of treatment successLISAK, Robert P; HOHLFELD, Reinhard.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, 98 p., SUP3Conference Proceedings

Insights for practice: Where mechanism of action meets patient managementLISAK, Robert P; KORNGOLD, Sam.Neurology. 2010, Vol 74, Num 1, issn 0028-3878, S70-S73, SUP1Conference Paper

Neurodegeneration in multiple sclerosis : Defining the problemBIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S2-S12 [11 p.], SUP3Conference Paper

Experimental models of neuroprotection relevant to multiple sclerosisBIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S2-S4, S32-S37 [9 p.], SUP3Conference Paper

Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosisBIRNBAUM, Gaty; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S2-S4, S13-S21 [12 p.], SUP3Conference Paper

Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?BIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S55-S57, S72-S82 [14 p.], SUP3Conference Paper

Theoretical constructs of neuronal preservation and repair in multiple sclerosisLUBLIN; YONG; HOHLFELD et al.HOHLFELD et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S43-S54, SUP3Conference Paper

Use of intravenous gamma globulins in neuroimmunologic diseasesLATOV, Norman; CHAUDHRY, Vinay; KOSKI, Carol Lee et al.Journal of allergy and clinical immunology. 2001, Vol 108, Num 4, pp S126-S132, issn 0091-6749, SUPConference Paper

Pathogenesis of axonal and neuronal damage in multiple sclerosisBIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S2-S4, S22-S31 [13 p.], SUP3Conference Paper

Evidence for neuroprotection and remyelination using imaging techniquesBIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S55-S57, S83-S90 [11 p.], SUP3Conference Paper

Discussion, Part II Clinical assessment of neuronal preservation and repair in multiple sclerosisARNOLD; ZIVADINOV; BIRNBAUM et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S91-S96, SUP3Conference Paper

Myasthenic crisis : Guidelines for prevention and treatmentJANI-ACSADI, Agnes; LISAK, Robert P.Journal of the neurological sciences. 2007, Vol 261, Num 1-2, pp 127-133, issn 0022-510X, 7 p.Article

Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosisBIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S2-S4, S38-S42 [8 p.], SUP3Conference Paper

Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?BIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S55-S57, S64-S71 [11 p.], SUP3Conference Paper

Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapyKHAN, Omar A; ZVARTAU-HIND, Marina; CAON, Christina et al.Multiple sclerosis. 2001, Vol 7, Num 3, pp 185-188, issn 1352-4585Article

Interferon-γ, tumor necrosis factor-α, and transforming growth factor-β inhibit cyclic AMP-induced Schwann cell differentiationLISAK, Robert P; BEALMEAR, Beverly; BENJAMINS, Joyce A et al.Glia (New York, NY. Print). 2001, Vol 36, Num 3, pp 354-363, issn 0894-1491Article

Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosisARNASON, Barry G; BERKOVICH, Regina; CATANIA, Anna et al.Multiple sclerosis. 2013, Vol 19, Num 2, pp 130-136, issn 1352-4585, 7 p.Article

Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia GravisBIN ZHANG; TZARTOS, John S; BELIMEZI, Maria et al.Archives of neurology (Chicago). 2012, Vol 69, Num 4, pp 445-451, issn 0003-9942, 7 p.Article

Dual role of inflammation in CNS diseaseBIRNBAUM, Gary; LEIST, Thomas P; LUBLIN, Fred D et al.Neurology. 2007, Vol 68, Num 22, issn 0028-3878, S55-S63 [9 p.], SUP3Conference Paper

A prospective, open-label treatment trial to compare the effect of IFNβ-1a (Avonex®), IFNβ-1b (Betaseron®), and glatiramer acetate (Copaxone®) on the relapse rate in relapsing- remitting multiple sclerosis: results after 18 months of therapyKHAN, Omar A; TSELIS, Alexandros C; KAMHOLZ, John A et al.Multiple sclerosis. 2001, Vol 7, Num 6, pp 349-353, issn 1352-4585Article